AstraZeneca and Daiichi Sankyo Partner with Summit on Datroway
AstraZeneca and Daiichi Sankyo enter clinical collaboration with Summit Therapeutics to evaluate Datroway in combination with ivonescimab across multiple tumor types.
Datroway Ivonescimab Combination | 05/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy